GlaxoSmithKline defends itself against activist Elliott, recognizing need for ‘improved and sustained value’
July 02, 2021 at 06:34 AM EDT
Pharma giant responds to attack from U.S. activist fund Elliott, backing CEO Emma Walmsley.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.